Physician profile
Steven Quan
NPI 1508391186
$944.07
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.81 · 2022: $290 · 2023: $330 · 2024: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $278.11 | 2023-2024 | Puraply, Apligraf |
| Treace Medical Concepts, INC. | $157.16 | 2022-2023 | |
| Convatec INC. | $130.06 | 2024 | |
| Stryker Corporation | $104.24 | 2021-2022 | |
| Abbvie INC. | $87.74 | 2023 | |
| Triad Life Sciences INC. | $65.39 | 2022 | |
| Smith+Nephew, INC. | $28.72 | 2023 | Regranex, Collagenase Santyl |
| Zimmer Biomet Holdings, INC. | $26.53 | 2023 | Cannulated Screws |
| Kairos Surgical INC | $15.50 | 2022 | |
| Bioventus LLC | $14.68 | 2023 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $14.43 | 2024 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $11.98 | 2022 | |
| Kerecis Limited | $9.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Quan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.